Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Gunther Laukien in 1960 and is headquartered in Billerica, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ROSENTHAL BOB | Director | Aug 15 '24 | Option Exercise | 23.37 | 12,500 | 292,075 | 35,647 | Aug 16 04:39 PM | ROSENTHAL BOB | Director | Aug 15 '24 | Sale | 63.14 | 4,684 | 295,748 | 30,963 | Aug 16 04:39 PM | ROSENTHAL BOB | Director | Aug 15 '24 | Proposed Sale | 61.47 | 4,684 | 287,925 | | Aug 15 05:41 PM | Requardt Hermann Fritz | Director | Mar 04 '24 | Option Exercise | 22.05 | 15,000 | 330,750 | 38,147 | Mar 06 04:05 PM | Requardt Hermann Fritz | Director | Mar 04 '24 | Sale | 90.06 | 15,000 | 1,350,898 | 23,147 | Mar 06 04:05 PM | Busse Falko | PRESIDENT, BIOSPIN GROUP | Feb 28 '24 | Option Exercise | 26.28 | 28,122 | 739,156 | 60,981 | Mar 01 04:05 PM | Busse Falko | PRESIDENT, BIOSPIN GROUP | Feb 28 '24 | Sale | 85.48 | 28,122 | 2,403,890 | 32,859 | Mar 01 04:05 PM | Prause Burkhard | PRES. & CEO, BRUKER BEST | Feb 22 '24 | Option Exercise | 43.17 | 5,450 | 235,292 | 32,384 | Feb 26 04:02 PM | Prause Burkhard | PRES. & CEO, BRUKER BEST | Feb 22 '24 | Sale | 83.30 | 15,319 | 1,276,073 | 17,065 | Feb 26 04:02 PM | LINTON WILLIAM A | Director | Dec 05 '23 | Option Exercise | 19.07 | 10,000 | 190,700 | 33,048 | Dec 07 04:01 PM |
|